title: Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
abstract: Complement factor H (FH) is an important regulator of the alternative complement pathway. The Y402H polymorphism within the seventh short consensus repeat of FH was recently shown to be associated with age-related macular degeneration, the most common cause of irreversible blindness in the Western world. We examined the effects of this polymorphism on various FH functions. FH purified from sera of age-related macular degeneration patients homozygous for the FH(402H) variant showed a significantly reduced binding to C-reactive protein (CRP), an acute phase protein, as compared with FH derived from unaffected controls homozygous for the FH(402Y) variant. Strongly reduced binding to CRP was also observed with a recombinant fragment of FH (short consensus repeat 5-7) containing the same amino acid change. Because the interaction of CRP and FH promotes complement-mediated clearance of cellular debris in a noninflammatory fashion, we propose that the reduced binding of FH(402H) to CRP could lead to an impaired targeting of FH to cellular debris and a reduction in debris clearance and enhanced inflammation along the macular retinal pigmented epithelium-choroid interface in individuals with age-related macular degeneration.
authors.affiliation: Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Haartmaninkatu 3, FI-00014 Helsinki, Finland.
authors.forename: Matti
authors.initials: M
authors.lastname: Laine
authors.forename: Hanna
authors.initials: H
authors.lastname: Jarva
authors.forename: Sanna
authors.initials: S
authors.lastname: Seitsonen
authors.forename: Karita
authors.initials: K
authors.lastname: Haapasalo
authors.forename: Markus J
authors.initials: MJ
authors.lastname: Lehtinen
authors.forename: Nina
authors.initials: N
authors.lastname: Lindeman
authors.forename: Don H
authors.initials: DH
authors.lastname: Anderson
authors.forename: Patrick T
authors.initials: PT
authors.lastname: Johnson
authors.forename: Irma
authors.initials: I
authors.lastname: Järvelä
authors.forename: T Sakari
authors.initials: TS
authors.lastname: Jokiranta
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Hageman
authors.forename: Ilkka
authors.initials: I
authors.lastname: Immonen
authors.forename: Seppo
authors.initials: S
authors.lastname: Meri
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002097:C-Reactive Protein / Q000235:genetics / Q000378:metabolism*; D017242:Complement Factor H / Q000235:genetics / Q000302:isolation & purification / Q000378:metabolism*; D005260:Female; D006720:Homozygote; D006801:Humans; D007249:Inflammation / Q000235:genetics / Q000378:metabolism; D008268:Macular Degeneration / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010857:Pigment Epithelium of Eye / Q000378:metabolism / Q000473:pathology; D011110:Polymorphism, Genetic; D011485:Protein Binding / Q000235:genetics; D012160:Retina / Q000378:metabolism / Q000473:pathology
chemical_list: D017242:Complement Factor H; D002097:C-Reactive Protein